Sigachi MENA FZCO has signed a Memorandum of Understanding (MoU) with Respilon, a company from the Czech Republic focused on developing new nanofiber technology.

This agreement is a key step in Sigachi's plan to grow into advanced ways of delivering medicines.

Sigachi and Respilon will work together to develop, make, and sell ways to deliver medicines using Respilon's special NUENEX® nanofiber technology. The partnership includes creating plans to sell relevant drug ingredients and formulations, using the technology that wraps them in nanofibers.

Amit Raj Sinha, Managing Director and CEO of Sigachi Industries Limited, said, "Working with Respilon fits perfectly with our goal to provide the next generation of medicine solutions that make treatments work better and improve the patient's experience. We are excited about what NUENEX® technology can do to change drug delivery systems around the world."

Roman Zima, Chief Business Officer of Respilon Group s.r.o, said, "We are happy to partner with Sigachi. Their deep knowledge of the industry and worldwide reach will help NUENEX® be used more quickly across medicine markets. Together, we hope to improve drug delivery with safer, more effective, and sustainable solutions for patients everywhere."